triazoles has been researched along with 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, B; Gao, L; Kannan, A; Kannan, K; Lin, Z; Moreno, MA; Shao, Q; Stack, BC; Suen, JY; Vural, E; Zhao, S | 1 |
| Ding, X; Gao, L; Liu, Z; Sun, Y; Wu, Q; Zeng, T | 1 |
| Belcheva, A; Boone, T; Chang, JCN; Cohen, AL; Darcourt, JG; Ensor, J; Hemati, P; Kaklamani, VG; Koca, E; Li, X; Murthy, A; Nair, S; Niravath, PA; Patel, TA; Qian, W; Ramshesh, PV; Wong, H; Zhao, J | 1 |
1 trial(s) available for triazoles and 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine
| Article | Year |
|---|---|
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoxazoles; Breast Neoplasms; Female; Hormones; Humans; Neoadjuvant Therapy; Nitriles; Pyrimidines; Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Triazoles | 2021 |
2 other study(ies) available for triazoles and 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine
| Article | Year |
|---|---|
Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth.
Topics: Animals; Apoptosis; Azepines; Benzoxazoles; Blotting, Western; Carcinoma, Merkel Cell; Cell Proliferation; Cellular Senescence; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Pyrimidines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; TOR Serine-Threonine Kinases; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Benzoxazoles; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Fungal Proteins; Gene Expression; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; TOR Serine-Threonine Kinases; Triazoles; Voriconazole | 2016 |